Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Revathy B Iyer

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 21, 2007
PET/CT of esophageal cancer: its role in clinical managementJohn F Bruzzi, Reginald F Munden, Mylene T Truong, et al.
Gynecologic Oncology|March 7, 2009
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancerKathleen M Schmeler, Saroj Vadhan-Raj, Pedro T Ramirez, et al.
Journal of Translational Medicine|April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinSachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.
Practical Radiation Oncology|April 7, 2022
Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer TreatmentJuliana Wu, David S Lakomy, Bryan M Fellman, et al.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
The Lancet. Oncology|October 14, 2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L Coleman, Linda R Duska, Pedro T Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
AJR. American Journal of Roentgenology|April 23, 2011
National CT colonography trial (ACRIN 6664): comparison of three full-laxative bowel preparations in more than 2500 average-risk patientsAmy K Hara, Mark D Kuo, Meridith Blevins, et al.
Gynecologic Oncology|July 15, 2014
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Radiographics : a Review Publication of the Radiological Society of North America, Inc|November 21, 2007
PET/CT of esophageal cancer: its role in clinical managementJohn F Bruzzi, Reginald F Munden, Mylene T Truong, et al.
Gynecologic Oncology|March 7, 2009
A phase II study of GM-CSF and rIFN-gamma1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancerKathleen M Schmeler, Saroj Vadhan-Raj, Pedro T Ramirez, et al.
Journal of Translational Medicine|April 11, 2006
Cytokines, GM-CSF and IFNgamma administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinSachin M Apte, Saroj Vadhan-Raj, Lorenzo Cohen, et al.
Practical Radiation Oncology|April 7, 2022
Longitudinal Changes in Bone Mineral Measurements Inside and Outside Radiation Fields Used for Cervical Cancer TreatmentJuliana Wu, David S Lakomy, Bryan M Fellman, et al.
Gynecologic Oncology|February 18, 2017
A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
International Journal of Radiation Oncology, Biology, Physics|January 22, 2008
Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for rectal cancerTse-Kuan Yu, Priya R Bhosale, Christopher H Crane, et al.
The Lancet. Oncology|October 14, 2011
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancerRobert L Coleman, Linda R Duska, Pedro T Ramirez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2007
Prospective study of the correlation between postoperative computed tomography scan and primary surgeon assessment in patients with advanced ovarian, tubal, and peritoneal carcinoma reported to have undergone primary surgical cytoreduction to residual disease 1 cm or lessDennis S Chi, Pedro T Ramirez, Jerrold B Teitcher, et al.
AJR. American Journal of Roentgenology|April 23, 2011
National CT colonography trial (ACRIN 6664): comparison of three full-laxative bowel preparations in more than 2500 average-risk patientsAmy K Hara, Mark D Kuo, Meridith Blevins, et al.
Gynecologic Oncology|July 15, 2014
A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancerRudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, et al.
Pageof 5